AXTI

AXTI remains in a Stage 4 decline with lower highs and lower lows under down-sloping EMAs, confirming a bearish medium-term bias. Price is trading below key EMAs but holding near the 200 DMA amid extreme oversold conditions, introducing execution timing uncertainty. Defer selling until there is a decisive breakdown below support.

• ↑Secured three-year $22M supply agreement with Coherent boosting revenue visibility.
• ↑Q1 2026 revenue rose 38.5% YoY to $26.9M; backlog exceeds $100M.
• ↓Export permit hurdles delay shipments and hinder revenue recognition.